Methods of induction of labor in women with obesity: A secondary analysis of two multicenter randomized controlled trials
- PMID: 38183287
- PMCID: PMC10867363
- DOI: 10.1111/aogs.14737
Methods of induction of labor in women with obesity: A secondary analysis of two multicenter randomized controlled trials
Abstract
Introduction: Obesity is an increasing public health concern worldwide and can lead to more complications in pregnancy and childbirth. Women with obesity more often require induction of labor for various indications. The aim of this study is to assess which method of induction of labor is safest and most effective in women with obesity.
Material and methods: This is a secondary analysis of two randomized controlled trials about induction of labor. Women with a term singleton pregnancy in cephalic presentation, an unfavorable cervix, intact membranes and without a previous cesarean section were randomly allocated to cervical priming with a Foley catheter or vaginal prostaglandin-E2-gel (PROBAAT-I) or a Foley catheter or oral misoprostol (PROBAAT-II). The inclusion and exclusion criteria for the studies were identical. Induction methods were compared in women with obesity (body mass index ≥30.0). Main outcomes were cesarean section and postpartum hemorrhage (blood loss >1000 mL).
Results: A total of 2664 women, were included in the trials, 517 of whom were obese: 254 women with obesity received a Foley catheter, 176 oral misoprostol and 87 prostaglandin E2 (PGE2). A cesarean section was performed in 29.1% of women allocated to Foley vs 22.2% in the misoprostol and 23.0% in the PGE2 groups. Comparisons between groups revealed no statistically significant differences: the relative risk [RR] was 1.31 (95% confidence interval [CI] 0.94-1.84) in the Foley vs misoprostol group and 1.27 (95% CI 0.83-1.95) in the Foley vs PGE2 group. The rates of postpartum hemorrhage were comparable (10.6%, 11.4% and 6.9%, respectively; P = 0.512). In women with obesity, more often a switch to another method occurred in the Foley group, (20.1% vs 6.3% in misoprostol vs 1.1% in the PGE2 group; P < 0.001). The risk of a failed Foley placement was higher in women with obesity than in women without obesity (8.3% vs 3.2%; adjusted odds ratio 3.12, 95% CI 1.65-5.90).
Conclusions: In women with obesity we found a nonsignificant trend towards an increased rate of cesarean sections in the group induced with a Foley catheter compared to oral misoprostol; however, the study lacked power for this subgroup analysis. The finding of a higher risk of failed placement of a Foley catheter in women with obesity can be used in shared decision making.
Keywords: Foley catheter; PGE1; PGE2 misoprostol; cervical ripening; labor, induced; obesity; prostaglandins.
© 2024 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).
Conflict of interest statement
Ben Willem Mol reports consultancy for ObsEva, Merck KGaA and Guerbet. The other authors have stated explicitly that they have no conflicts of interest in connection with this article.
Similar articles
-
Combination of Foley and prostaglandins versus Foley and oxytocin for cervical ripening: a network meta-analysis.Am J Obstet Gynecol. 2020 Nov;223(5):743.e1-743.e17. doi: 10.1016/j.ajog.2020.05.007. Epub 2020 May 7. Am J Obstet Gynecol. 2020. PMID: 32387325
-
Transcervical Foley Balloon Plus Vaginal Misoprostol versus Vaginal Misoprostol Alone for Cervical Ripening in Nulliparous Obese Women: A Multicenter, Randomized, Comparative-Effectiveness Trial.Am J Perinatol. 2021 Aug;38(S 01):e123-e128. doi: 10.1055/s-0040-1708805. Epub 2020 Apr 16. Am J Perinatol. 2021. PMID: 32299108 Clinical Trial.
-
Foley Catheter or Oral Misoprostol for Induction of Labor in Women with Term Premature Rupture of Membranes: A Randomized Multicenter Trial.Am J Perinatol. 2016 Jul;33(9):866-72. doi: 10.1055/s-0036-1580608. Epub 2016 Mar 31. Am J Perinatol. 2016. PMID: 27031055 Clinical Trial.
-
Foley catheter versus vaginal misoprostol: randomized controlled trial (PROBAAT-M study) and systematic review and meta-analysis of literature.Am J Perinatol. 2014 Feb;31(2):145-56. doi: 10.1055/s-0033-1341573. Epub 2013 Apr 5. Am J Perinatol. 2014. PMID: 23564065 Clinical Trial.
-
Intracervical Foley Catheter Plus Intravaginal Misoprostol vs Intravaginal Misoprostol Alone for Cervical Ripening: A Meta-Analysis.Int J Environ Res Public Health. 2020 Mar 11;17(6):1825. doi: 10.3390/ijerph17061825. Int J Environ Res Public Health. 2020. PMID: 32168947 Free PMC article.
Cited by
-
Inpatient vaginal dinoprostone vs outpatient balloon catheters for cervical ripening in induction of labor: An individual participant data meta-analysis of randomized controlled trials.Acta Obstet Gynecol Scand. 2025 Jun;104(6):1041-1055. doi: 10.1111/aogs.15092. Epub 2025 Mar 25. Acta Obstet Gynecol Scand. 2025. PMID: 40134109 Free PMC article. Review.
References
-
- Obesity and overweight: World Health Organization. 2021. Available from: https://www.who.int/news‐room/fact‐sheets/detail/obesity‐and‐overweight#.... Accessed January, 2022.
-
- CBS Statline Lengte en gewicht van personen, ondergewicht en overgewicht; vanaf 1981 Centraal Bureau voor de Statistiek. Available from: https://opendata.cbs.nl/statline/#/CBS/nl/dataset/81565NED/table?ts=1589.... Accessed January, 2022.
-
- Robinson HE, O'Connell CM, Joseph KS, McLeod NL. Maternal outcomes in pregnancies complicated by obesity. Obstet Gynecol. 2005;106:1357‐1364. - PubMed
-
- Weiss JL, Malone FD, Emig D, et al. Obesity, obstetric complications and cesarean delivery rate–a population‐based screening study. Am J Obstet Gynecol. 2004;190:1091‐1097. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources